Maura Barry, M.D.
Associate Professor of Medicine, Division of Hematology and Oncology
Associate Director, Hematology and Medical Oncology Fellowship Program
Executive Director, Women's Health and Cancer Conference, UVM Cancer Center
Director of Applied Informatics, UVM Cancer Center
Medical Oncologist, UVM Health Network
- M.D., Rutgers New Jersey Medical School
- B.A., Barnard College
Department of Medicine, Division of Hematology and Oncology
University of Vermont Cancer Center
BIO
Dr. Maura "Molly" Barry is a medical oncologist at the University of Vermont Medical Center and an associate professor at the Larner College of Medicine at UVM in Burlington, VT. At UVM Medical Center, Dr. Barry practices head and neck and GI oncology. Her research interests include medical education, mentorship, and supportive care.
Dr. Barry's postdoctoral training
Fellow in Hematology and Oncology, New York University
Chief Medical Resident, Rutgers New Jersey Medical School/University Hospital UMDNJ- NJMS Department of Medicine
Resident in Internal Medicine, Rutgers New Jersey Medical School; University Hospital; Department of Veterans Affairs New Jersey Health Care System;
Professional Societies
ASCO
Publications
Dr. Barry's publications on PubMed
Awards and Achievements
Larner College of Medicine Professionalism Accolade 2021-2022 AY
Department of Medicine Distinguished Mentor Award- Nominee 2022
ASCO Education Scholars Program Graduate 2022
Polaris Award for Outstanding Mentorship- Nominee 2025
Area(s) of expertise
Patient Clinical Care
Medical Education
Mentorship
Supportive Care
Dr. Barry's recent publications
Higgins LM, Lester-Coll NH, Ades S, Barry MM, Borrazzo EC, Ganguly EK, Anker CJ. 'CROSS'-ing into the 'Real World': a retrospective cohort study of patients receiving trimodality and bimodality therapy for esophageal cancer. J Gastrointest Oncol. 2023 Apr 29;14(2):480-493. doi: 10.21037/jgo-22-633. Epub 2023 Apr 24. PubMed PMID:
Chidharla A, Utengen A, Attai DJ, Drake EK, van Londen GJ, Subbiah IM, Henry E, Murphy M, Barry MM, Manochakian R, Moerdler S, Loeb S, Graff SL, Leyfman Y, Thompson MA, Markham MJ.
JCO Oncol Pract. 2022 Aug;18(8):566-571. doi: 10.1200/OP.21.00761. Epub 2022 Mar 21.
PMID: 35312343 Review.
Social Media and the Quest for Equity and Diversity in Oncology: On Safe Spaces and the Concept of the Public Physician.
Florez N, Karmo M, Beltrán Ponce S, Barry MM, Henry E, Katz MS, Dizon DS, Hylton HM; Collaboration for Outcomes using Social Media in Oncology (COSMO).
JCO Oncol Pract. 2022 Aug;18(8):572-577. doi: 10.1200/OP.21.00762. Epub 2022 Jul 14.
PMID: 35834761 Review
Cancer Care in the Wake of a Cyberattack: How to Prepare and What to Expect.
Ades S, Herrera DA, Lahey T, Thomas AA, Jasra S, Barry M, Sprague J, Dittus K, Plante TB, Kelly J, Kaufman PA, Khan F, Hammond CJ, Gernander K, Parsons P, Holmes C.
JCO Oncol Pract. 2022 Jan;18(1):23-34. doi: 10.1200/OP.21.00116. Epub 2021 Aug 2.
PMID: 34339260 Review.
Nivolumab-Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from Immunotherapy.
Gergi M, Landry KK, Ades S, Barry M, Zakai NA, Herrera DA.
Oncologist. 2020 Dec;25(12):1009-1012. doi: 10.1002/onco.13553. Epub 2020 Oct 23.
PMID: 33017484 Free PMC article. Review.
NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors.
Yang MX, Coates RF, Ambaye A, Cortright V, Mitchell JM, Buskey AM, Zubarik R, Liu JG, Ades S, Barry MM.
Biomark Res. 2018 Apr 18;6:15. doi: 10.1186/s40364-018-0129-8. eCollection 2018.
PMID: 29713473 Free PMC article.
Social Media and Professional Development for Oncology Professionals.
When Clinical Trial Participation Is Not an Option in the Era of Personalized Medicine: The Case of Two Patients.
Verschraegen CF, Rehman H, Pulluri B, DeKay J, Barry M, Folefac E, Dittus K, Holmes C, Sprague J, Ades S, Gibson PC.
Oncology. 2017;92(1):55-60. doi: 10.1159/000450712. Epub 2016 Nov 8.
PMID: 2782093
Teams and Teamwork in Cancer Care Delivery: Shared Mental Models to Improve Planning for Discharge and Coordination of Follow-Up Care.
Page JS, Lederman L, Kelly J, Barry MM, James TA.
J Oncol Pract. 2016 Nov;12(11):1053-1058. doi: 10.1200/JOP.2016.013888. Epub 2016 Oct 31.
PMID: 27858547
Bio
Dr. Maura "Molly" Barry is a medical oncologist at the University of Vermont Medical Center and an associate professor at the Larner College of Medicine at UVM in Burlington, VT. At UVM Medical Center, Dr. Barry practices head and neck and GI oncology. Her research interests include medical education, mentorship, and supportive care.
Dr. Barry's postdoctoral training
Fellow in Hematology and Oncology, New York University
Chief Medical Resident, Rutgers New Jersey Medical School/University Hospital UMDNJ- NJMS Department of Medicine
Resident in Internal Medicine, Rutgers New Jersey Medical School; University Hospital; Department of Veterans Affairs New Jersey Health Care System;
Professional Societies
ASCO
Publications
Awards and Achievements
Larner College of Medicine Professionalism Accolade 2021-2022 AY
Department of Medicine Distinguished Mentor Award- Nominee 2022
ASCO Education Scholars Program Graduate 2022
Polaris Award for Outstanding Mentorship- Nominee 2025
Areas of Expertise
Patient Clinical Care
Medical Education
Mentorship
Supportive Care
Dr. Barry's recent publications
Higgins LM, Lester-Coll NH, Ades S, Barry MM, Borrazzo EC, Ganguly EK, Anker CJ. 'CROSS'-ing into the 'Real World': a retrospective cohort study of patients receiving trimodality and bimodality therapy for esophageal cancer. J Gastrointest Oncol. 2023 Apr 29;14(2):480-493. doi: 10.21037/jgo-22-633. Epub 2023 Apr 24. PubMed PMID:
Chidharla A, Utengen A, Attai DJ, Drake EK, van Londen GJ, Subbiah IM, Henry E, Murphy M, Barry MM, Manochakian R, Moerdler S, Loeb S, Graff SL, Leyfman Y, Thompson MA, Markham MJ.
JCO Oncol Pract. 2022 Aug;18(8):566-571. doi: 10.1200/OP.21.00761. Epub 2022 Mar 21.
PMID: 35312343 Review.
Social Media and the Quest for Equity and Diversity in Oncology: On Safe Spaces and the Concept of the Public Physician.
Florez N, Karmo M, Beltrán Ponce S, Barry MM, Henry E, Katz MS, Dizon DS, Hylton HM; Collaboration for Outcomes using Social Media in Oncology (COSMO).
JCO Oncol Pract. 2022 Aug;18(8):572-577. doi: 10.1200/OP.21.00762. Epub 2022 Jul 14.
PMID: 35834761 Review
Cancer Care in the Wake of a Cyberattack: How to Prepare and What to Expect.
Ades S, Herrera DA, Lahey T, Thomas AA, Jasra S, Barry M, Sprague J, Dittus K, Plante TB, Kelly J, Kaufman PA, Khan F, Hammond CJ, Gernander K, Parsons P, Holmes C.
JCO Oncol Pract. 2022 Jan;18(1):23-34. doi: 10.1200/OP.21.00116. Epub 2021 Aug 2.
PMID: 34339260 Review.
Nivolumab-Induced Thrombotic Thrombocytopenic Purpura in a Patient with Anal Squamous Cell Carcinoma: A Lesson on Hematologic Toxicity from Immunotherapy.
Gergi M, Landry KK, Ades S, Barry M, Zakai NA, Herrera DA.
Oncologist. 2020 Dec;25(12):1009-1012. doi: 10.1002/onco.13553. Epub 2020 Oct 23.
PMID: 33017484 Free PMC article. Review.
NKX2.2, PDX-1 and CDX-2 as potential biomarkers to differentiate well-differentiated neuroendocrine tumors.
Yang MX, Coates RF, Ambaye A, Cortright V, Mitchell JM, Buskey AM, Zubarik R, Liu JG, Ades S, Barry MM.
Biomark Res. 2018 Apr 18;6:15. doi: 10.1186/s40364-018-0129-8. eCollection 2018.
PMID: 29713473 Free PMC article.
Social Media and Professional Development for Oncology Professionals.
When Clinical Trial Participation Is Not an Option in the Era of Personalized Medicine: The Case of Two Patients.
Verschraegen CF, Rehman H, Pulluri B, DeKay J, Barry M, Folefac E, Dittus K, Holmes C, Sprague J, Ades S, Gibson PC.
Oncology. 2017;92(1):55-60. doi: 10.1159/000450712. Epub 2016 Nov 8.
PMID: 2782093
Teams and Teamwork in Cancer Care Delivery: Shared Mental Models to Improve Planning for Discharge and Coordination of Follow-Up Care.
Page JS, Lederman L, Kelly J, Barry MM, James TA.
J Oncol Pract. 2016 Nov;12(11):1053-1058. doi: 10.1200/JOP.2016.013888. Epub 2016 Oct 31.
PMID: 27858547